So this is what no one gets and despite the fact that I'm a long this has to be explained bc I'm a physician first. Given our results showing a Clinically significant decrease in mortality and the fact that cd-12 is now OLE bc of this and we have eind we won't get any pts who want to enroll in a double blind study and even if we did it's UNETHICAL!!!! This is why the CD-12 is now OLE!!!....this is also why the fda changed the endpoint to length of stay and not mortality bc if/when it proves AGAIN to decrease mortality they could be blamed for knowingly harming the control group. Please someone have them address this issue during the q and a bc I'm about to lose my xxxx and so are a bunch of my colleagues.